evaluate the pharmaceuticals company wegovy on how glp-1 works Drugs and Eating Disorders: A Hidden Risk in Weight Loss Revolution – The Chicago Council Science and Technology The Big Trial of a

The first oral (pill) form of a GLP-1 (semaglutide, brand name Wegovy) became available in January 2026

Mehmet Oz said even a comment on GLP-1 coverage would be market moving. We break down what that means, why the Trump administration shelved a rule that wouldve added obesity meds to Medicare coverage, and how that decision might now be a bargaining chip to lower drug prices in exchange for tougher enforcement on compounding

Oral drops therapy that mimics natural GLP-1 to improve appetite control and metabolic efficiency

As the focus was on establishing the acute direct effects of liraglutide, and not primarily those resulting from liraglutide-induced weight loss, participants were instructed not to change their diet, exercise program or daily routines during the trial to maintain their pre-trial body weight, and a wash-out period of 68 weeks was included between the two trial periods to avoid any metabolic carry-over effects of a body weight loss